Selenosartans: Novel selenophene analogues of milfasartan and eprosartan

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 3, 2008, Pages 1241-1244

  Grange, Rebecca L ^a,b   Ziogas, James ^a   North, Andrea J ^a,b   Angus, James A ^a   Schiesser, Carl H ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

AT1 receptor antagonist sartan

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; EPROSARTAN; MILFASARTAN; SELENIUM; SELENOSARTAN; SULFUR; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CELL ASSAY; CHO CELL; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ACRYLATES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CRICETINAE; FEMALE; IMIDAZOLES; MOLECULAR STRUCTURE; ORGANOSELENIUM COMPOUNDS; OVARY; RECEPTOR, ANGIOTENSIN, TYPE 1; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SULFUR; THIOPHENES;

EID: 38749122815     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.11.136     Document Type: Article

References (30)

1. For an excellent review on toxicity and selenium-based drugs in medicine, see:. Carland M., and Fenner T. In: Gielen M., and Tiekink E.R.T. (Eds). Metallotherapeutic Drugs and Metal-based Diagnostic Agents (2005), John Wiley and Sons, Chichester
2. Grange R.L., Ziogas J., Angus J.A., and Schiesser C.H. Tetrahedron Lett. 48 (2007) 6301
3. Aumann K.M., Scammells P.J., White J.M., and Schiesser C.H. Org. Biomol. Chem. 5 (2007) 1276
4. Ashton T.D., Aumann K.M., Baker S.P., Schiesser C.H., and Scammells P.J. Biorg, Med. Chem. Lett. 17 (2007) 6779
5. Salimbeni A., Canevotti R., Paleari F., Poma D., Caliari S., Fici F., Cirillo R., Renzetti A.R., Subissi A., Belvisi L., Bravi G., Scolastico C., and Giachetti A. J. Med. Chem. 38 (1995) 4806
6. Robins G.W., and Scott L.J. Drugs 65 (2005) 2355
7. Weinstock J., Keenan R.M., Samanen J., Hempel J., Finkelstein J.A., Franz R.G., Gaitanopoulos D.E., Girard G.R., Gleason J.G., Hill D.T., Morgan T.M., Peishoff C.E., Aiyar N., Brooks D.P., Fredrickson T.A., Ohlstein E.H., Ruffolo R.R., Stack E.J., Sulpizio A.C., Weidley E.F., and Edwards R.M. J. Med. Chem. 34 (1991) 1514
8. Keenan R.M., Weinstock J., Finkelstein J.A., Franz R.G., Gaitanopoulos D.E., Girard G.R., Hill D.T., Morgan T.M., Samanen J.M., Hempel J., Eggleston D.S., Aiyar N., Griffin E., Ohlstein E.H., Stack E.J., Weidley E.F., and Edwards R. J. Med. Chem. 35 (1992) 3858
9. Keenan R.M., Weinstock J., Finkelstein J.A., Franz R.G., Gaitanopoulos D.E., Girard G.R., Hill D.T., Morgan T.M., Samanen J.M., Peishoff C.E., Tucker L.M., Aiyar N., Griffin E., Ohlstein E.H., Stack E.J., Weidley E.F., and Edwards R.M. J. Med. Chem. 36 (1993) 1880
10. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., and Herblin W.F. Trends Pharmacol. Sci. 12 (1991) 55
11. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.M., and Smith R.D. Pharmacol. Rev. 45 (1993) 205
12. Goodfriend T.L., Elliott M.E., and Catt K.J. N. Engl. J. Med. 334 (1996) 1649
13. Johnston C.I., Naitoh M., and Burrell L.M. J. Hypertens. 15 (1997) S3
14. Burnier M., and Brunner H.R. Lancet 355 (2000) 637
15. Wexler R.R., Greenlee W.J., Irvin J.D., Goldberg M.R., Prendergast K., Smith R.D., and Timmermans P.B.M.W.M. J. Med. Chem. 39 (1996) 625
16. Csajka, C.; Buclin, T.; Fattinger, K.; Brunner, H. R.; Biollaz, J. Clin. Pharmacokinet. 202, 41, 137.
17. Catalioto R., Porchia R., Renzetti A.R., Criscuoli M., Subissi A., and Giachetti A. Eur. J. Pharmacol. 280 (1995) 285
18. Yur'ev Y.K., and Mezentsova N.N. Zhur. Obshcheǐ Khim. 27 (1957) 179
19. Yur'ev Y.K., and Mezentsova N.N. Chem. Abstr. 51 (1957) 12878b
20. Prasad K. Int. J. Angiol. 13 (2004) 59
21. Yur'ev Y.K., Sadovaya N.K., and Grekova E.A. J. Gen. Chem. USSR 34 (1964) 841
22. Franchetti P., Cappellacci L., Abu Sheikha G., Jayaraman H.N., Gurudutt V.V., Sint T., Schneider B.P., Jones W.D., Goldstein B.M., Perra G., De Montis A., Loi A.G., La Colla P., and Grifantini M. J. Med. Chem. 40 (1997) 1731
23. Hallberg A., Liljefors S., and Pedaja P. Synth. Commun. 11 (1981) 29
24. Lyons J.E., Schiesser C.H., and Sutej K. J. Org. Chem. 58 (1993) 5632
25. Partial transesterification occurred in conjunction with selenation.
26. Franchetti P., Cappellacci L., Abu Sheikha G., Jayaraman H.N., Gurudutt V.V., Sint T., Schneider B.P., Jones W.D., Goldstein B.M., Perra G., De Montis A., Loi A.G., La Colla P., and Grifantini M. J. Med. Chem. 40 (1997) 1731
27. Lam, L. K. T.; Ahmed, N. US Patent 20020165215, 2002.
28. Saito H., Ukai S., Iwatsuki S., Itoh T., and Kubo M. Macromolecules 28 (1995) 8363
29. Lew M.J., Ziogas J., and Christopoulos A. Trends Pharmacol. Sci. 21 (2000) 376
30. Rückel T., Biamonte M., Grippi-Vallotton T., Arkinstall S., Cambet Y., Camps M., Chabert C., Church D.J., Halazy S., Jiang X., Martinou I., Nichols A., Sauer W., and Gotteland J.-P. J. Med. Chem. 47 (2004) 6921